AlveoliX AG

In-vitro lung model for drug testing

AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at improving preclinical decision-making and thus reducing drug development costs.

News

23.05.2025 Promising Swiss innovations unveiled at VivaTech 2025 (startupticker.ch)

31.10.2024 AlveoliX and AMYRA report breakthroughs (startupticker.ch)

03.10.2024 EU funds AI-driven medical projects powered by Swiss startups (startupticker.ch)

Milestones/News

13.06.2017 Nominated at the Swiss Medtech Award 2017

01.02.2017 First customer for our lung-on-chip :-)

24.11.2016 Selected to present the AlveoliX lung-on-chip prototype at the Swiss Innovation Forum

27.04.2016 The Swiss President, Johannes Schneider Ammann visits AlveoliX

07.03.2016 Exclusive license agreement signed with the University of Bern

01.02.2016 Financial support from the Economic Promotion of the Canton of Berne

13.01.2015 AlveoliX wins the Ypsomed Second Prize

05.01.2015 The Lung-on-Chip in the News at the Swiss French Radio

02.01.2015 The Breathing Lung-on-Chip published in Lab Chip

Documents

Videos and Presentations

Swiss Medtech Award Lung on Chip

Login

AlveoliX AG

News

Milestones/News

Documents

Videos and Presentations